Ghila Luiza, Bjørlykke Yngvild, Legøy Thomas Aga, Vethe Heidrun, Furuyama Kenichiro, Chera Simona, Ræder Helge
Department of Clinical Science, Faculty of Medicine, University of Bergen, 5021 Bergen, Norway.
Department of Genetic Medicine & Development, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland.
Biomedicines. 2020 Jun 27;8(7):179. doi: 10.3390/biomedicines8070179.
Mutations in the hepatocyte nuclear factor 4α (HNF4α) gene affect prenatal and postnatal pancreas development, being characterized by insulin-producing β-cell dysfunction. Little is known about the cellular and molecular mechanisms leading to β-cell failure as result of HNF4α mutation. In this study, we compared the miRNA profile of differentiating human induced pluripotent stem cells (hiPSC) derived from HNF4α mutation carriers and their family control along the differentiation timeline. Moreover, we associated this regulation with the corresponding transcriptome profile to isolate transcript-miRNA partners deregulated in the mutated cells. This study uncovered a steep difference in the miRNA regulation pattern occurring during the posterior foregut to pancreatic endoderm transition, defining early and late differentiation regulatory windows. The pathway analysis of the miRNAome-transcriptome interactions revealed a likely gradual involvement of HNF4α mutation in p53-mediated cell cycle arrest, with consequences for the proliferation potential, survival and cell fate acquisition of the differentiating cells. The present study is based on bioinformatics approaches and we expect that, pending further experimental validation, certain miRNAs deregulated in the HNF4α cells would prove useful for therapy.
肝细胞核因子4α(HNF4α)基因突变会影响胰腺的产前和产后发育,其特征是产生胰岛素的β细胞功能障碍。对于HNF4α突变导致β细胞功能衰竭的细胞和分子机制,我们了解甚少。在本研究中,我们比较了来自HNF4α突变携带者及其家族对照的分化人诱导多能干细胞(hiPSC)在分化过程中的miRNA谱。此外,我们将这种调控与相应的转录组谱相关联,以分离在突变细胞中失调的转录本-miRNA对。本研究揭示了在前肠后部向胰腺内胚层转变过程中miRNA调控模式的显著差异,定义了早期和晚期分化调控窗口。对miRNA组-转录组相互作用的通路分析表明,HNF4α突变可能逐渐参与p53介导的细胞周期阻滞,这对分化细胞的增殖潜能、存活和细胞命运获得产生影响。本研究基于生物信息学方法,我们预计,在进一步的实验验证之前,在HNF4α细胞中失调的某些miRNA将被证明对治疗有用。